This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
Dublin: 4 °C Thursday 20 February, 2020

Pfizer cancels €400m expansion at Dublin plant

The plan was dependent on the success of a new cholesterol-reducing drug.

Image: Pfizer

PFIZER HAS CANCELLED a planned €400 million expansion at its Grange Castle plant in Clondalkin, Dublin.

The pharmaceutical company didn’t formally announce the investment, but recently sought planning permission for the development of the site.

In a statement it said the proposal was dependent on the success of clinical trials of bococizumab, a cholesterol-reducing drug.

The extension would have created 350 permanent jobs and over 1,000 roles during construction.

Grange Castle Grange Castle Source: Pfizer

A spokesperson for Pfizer said: “Following the decision to discontinue the development of bococizumab, part of the potential expansion for which the planning permission was sought will not now go ahead.

Expansion in relation to other incoming products will continue as planned involving investment, recruitment and new technology.

“Current and future development at Grange Castle, which is one of Pfizer’s leading biotechnology sites manufacturing a broad portfolio of biologic medicines and vaccines, is based on a number of commercialised products and pipeline compounds.”

Pfizer employs more than 3,000 people at plants in Dublin, Kildare, Cork and Sligo.

Read: Fine Gael is most popular party as Fianna Fáil loses ground

Read: Top Irish PR body seeks to curb rogue ‘influencers’ being paid to sell products and not admitting it

  • Share on Facebook
  • Email this article

About the author:

Órla Ryan

Read next: